Envoy Medical, Inc.
COCH
$0.66
$0.045.62%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -15.22% | 78.57% | -25.00% | 14.71% | -22.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -15.22% | 78.57% | -25.00% | 14.71% | -22.03% |
| Cost of Revenue | 38.50% | -86.62% | 8.56% | -4.49% | 47.71% |
| Gross Profit | -52.22% | 146.96% | -22.90% | 11.86% | -91.49% |
| SG&A Expenses | -6.24% | -13.60% | 36.61% | 16.55% | -10.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.40% | 36.57% | 14.36% | 4.63% | 4.25% |
| Operating Income | -16.68% | -36.18% | -14.80% | -4.49% | -4.57% |
| Income Before Tax | 12.95% | -42.62% | -8.76% | -44.16% | 20.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 12.95% | -42.62% | -8.76% | -44.16% | 20.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 12.95% | -42.62% | -8.76% | -44.16% | 20.29% |
| EBIT | -16.68% | -36.18% | -14.80% | -4.49% | -4.57% |
| EBITDA | -16.65% | -35.86% | -14.40% | -3.64% | -4.04% |
| EPS Basic | 70.81% | 31.59% | 10.09% | -13.66% | 14.62% |
| Normalized Basic EPS | 73.11% | 5.90% | 7.35% | -25.41% | 30.47% |
| EPS Diluted | 70.81% | 31.59% | 10.09% | -13.66% | 14.62% |
| Normalized Diluted EPS | 73.11% | 5.90% | 7.35% | -25.41% | 30.47% |
| Average Basic Shares Outstanding | 223.23% | 47.17% | 17.38% | 14.97% | 14.66% |
| Average Diluted Shares Outstanding | 223.23% | 47.17% | 17.38% | 14.97% | 14.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | 1.00% | -- | -- |